SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-005034
Filing Date
2021-03-04
Accepted
2021-03-04 17:12:11
Documents
27
Period of Report
2021-03-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K rvph20210304_8k.htm 8-K 26863
2 EXHIBIT 99.1 ex_231771.htm EX-99.1 14689
3 EXHIBIT 99.2 ex_231873.htm EX-99.2 9480
4 a01.jpg GRAPHIC 48731
5 a02.jpg GRAPHIC 102500
6 a03.jpg GRAPHIC 72500
7 a04.jpg GRAPHIC 54479
8 a05.jpg GRAPHIC 55042
9 a06.jpg GRAPHIC 71100
10 a07.jpg GRAPHIC 56976
11 a08.jpg GRAPHIC 25851
12 a09.jpg GRAPHIC 81344
13 a10.jpg GRAPHIC 76413
14 a11.jpg GRAPHIC 64317
15 a12.jpg GRAPHIC 47687
16 a13.jpg GRAPHIC 66288
17 a14.jpg GRAPHIC 82029
18 a15.jpg GRAPHIC 81634
19 a16.jpg GRAPHIC 24681
20 a17.jpg GRAPHIC 87854
21 a18.jpg GRAPHIC 73448
22 a19.jpg GRAPHIC 69574
23 a20.jpg GRAPHIC 51668
24 a21.jpg GRAPHIC 72395
25 a22.jpg GRAPHIC 72553
26 a23.jpg GRAPHIC 34963
27 reviva.jpg GRAPHIC 7549
  Complete submission text file 0001437749-21-005034.txt   2090831
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38634 | Film No.: 21715209
SIC: 2834 Pharmaceutical Preparations